The aim of this study was not simply to confirm established immunohistochemical phenotypes, but to explore whether tumor size and the Ki-67 proliferation index correlate with malignancy status within a homogeneous cohort of surgically treated primary small bowel tumors, and to describe subtype-specific patterns in an anatomical and histological context. This evidence concerns the gene MKI67 and small intestine neoplasm.